Financial OutlookImproved profitability, controlled capex and working capital improvement should allow the company to grow free cash flow towards the €3bn target by FY28.
Market GrowthNorth America continued to shine, led by coffee creamers (double-digit), High-Protein, as well as Activia which is enjoying particularly strong momentum as its health attributes seem to resonate with consumers.
Sales Performance3Q24 sales beat is another proof-point of the all-important EDP turnaround with North America shining again thanks to strong momentum in High-Protein and Coffee Creamers, and Europe back to volume-led.